217 related articles for article (PubMed ID: 24562062)
1. High baseline BDNF serum levels and early psychopathological improvement are predictive of treatment outcome in major depression.
Mikoteit T; Beck J; Eckert A; Hemmeter U; Brand S; Bischof R; Holsboer-Trachsler E; Delini-Stula A
Psychopharmacology (Berl); 2014 Aug; 231(15):2955-65. PubMed ID: 24562062
[TBL] [Abstract][Full Text] [Related]
2. Improved Alertness Is Associated with Early Increase in Serum Brain-Derived Neurotrophic Factor and Antidepressant Treatment Outcome in Major Depression.
Mikoteit T; Hemmeter U; Eckert A; Brand S; Bischof R; Delini-Stula A; Holsboer-Trachsler E; Beck J
Neuropsychobiology; 2015; 72(1):16-28. PubMed ID: 26337518
[TBL] [Abstract][Full Text] [Related]
3. The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: a pilot study.
Tadić A; Wagner S; Schlicht KF; Peetz D; Borysenko L; Dreimüller N; Hiemke C; Lieb K
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):415-20. PubMed ID: 20732374
[TBL] [Abstract][Full Text] [Related]
4. Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients.
Gonul AS; Akdeniz F; Taneli F; Donat O; Eker C; Vahip S
Eur Arch Psychiatry Clin Neurosci; 2005 Dec; 255(6):381-6. PubMed ID: 15809771
[TBL] [Abstract][Full Text] [Related]
5. Relationships between serum BDNF and the antidepressant effect of acute exercise in depressed women.
Meyer JD; Koltyn KF; Stegner AJ; Kim JS; Cook DB
Psychoneuroendocrinology; 2016 Dec; 74():286-294. PubMed ID: 27697714
[TBL] [Abstract][Full Text] [Related]
6. BDNF plasma levels variations in major depressed patients receiving duloxetine.
Fornaro M; Escelsior A; Rocchi G; Conio B; Magioncalda P; Marozzi V; Presta A; Sterlini B; Contini P; Amore M; Fornaro P; Martino M
Neurol Sci; 2015 May; 36(5):729-34. PubMed ID: 25501804
[TBL] [Abstract][Full Text] [Related]
7. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT.
Allen AP; Naughton M; Dowling J; Walsh A; Ismail F; Shorten G; Scott L; McLoughlin DM; Cryan JF; Dinan TG; Clarke G
J Affect Disord; 2015 Nov; 186():306-11. PubMed ID: 26275358
[TBL] [Abstract][Full Text] [Related]
8. Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression.
Vanicek T; Kranz GS; Vyssoki B; Fugger G; Komorowski A; Höflich A; Saumer G; Milovic S; Lanzenberger R; Eckert A; Kasper S; Frey R
Brain Stimul; 2019; 12(4):1041-1050. PubMed ID: 31000384
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial.
Raskin J; Wiltse CG; Siegal A; Sheikh J; Xu J; Dinkel JJ; Rotz BT; Mohs RC
Am J Psychiatry; 2007 Jun; 164(6):900-9. PubMed ID: 17541049
[TBL] [Abstract][Full Text] [Related]
10. Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression.
Dreimüller N; Schlicht KF; Wagner S; Peetz D; Borysenko L; Hiemke C; Lieb K; Tadić A
Neuropharmacology; 2012 Jan; 62(1):264-9. PubMed ID: 21803060
[TBL] [Abstract][Full Text] [Related]
11. Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine.
Matrisciano F; Bonaccorso S; Ricciardi A; Scaccianoce S; Panaccione I; Wang L; Ruberto A; Tatarelli R; Nicoletti F; Girardi P; Shelton RC
J Psychiatr Res; 2009 Jan; 43(3):247-54. PubMed ID: 18511076
[TBL] [Abstract][Full Text] [Related]
12. Relationship Between Hippocampal Volume, Serum BDNF, and Depression Severity Following Electroconvulsive Therapy in Late-Life Depression.
Bouckaert F; Dols A; Emsell L; De Winter FL; Vansteelandt K; Claes L; Sunaert S; Stek M; Sienaert P; Vandenbulcke M
Neuropsychopharmacology; 2016 Oct; 41(11):2741-8. PubMed ID: 27272769
[TBL] [Abstract][Full Text] [Related]
13. Electroconvulsive therapy improves clinical manifestations of treatment-resistant depression without changing serum BDNF levels.
Rapinesi C; Kotzalidis GD; Curto M; Serata D; Ferri VR; Scatena P; Carbonetti P; Napoletano F; Miele J; Scaccianoce S; Del Casale A; Nicoletti F; Angeletti G; Girardi P
Psychiatry Res; 2015 Jun; 227(2-3):171-8. PubMed ID: 25910420
[TBL] [Abstract][Full Text] [Related]
14. Brain-derived neurotrophic factor in generalized anxiety disorder: results from a duloxetine clinical trial.
Ball S; Marangell LB; Lipsius S; Russell JM
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():217-21. PubMed ID: 23313564
[TBL] [Abstract][Full Text] [Related]
15. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
16. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study.
Aydemir O; Deveci A; Taneli F
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):261-5. PubMed ID: 15694233
[TBL] [Abstract][Full Text] [Related]
17. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053
[TBL] [Abstract][Full Text] [Related]
18. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?
Fava M; Mallinckrodt CH; Detke MJ; Watkin JG; Wohlreich MM
J Clin Psychiatry; 2004 Apr; 65(4):521-30. PubMed ID: 15119915
[TBL] [Abstract][Full Text] [Related]
19. Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.
Shelton RC; Prakash A; Mallinckrodt CH; Wohlreich MM; Raskin J; Robinson MJ; Detke MJ
Int J Clin Pract; 2007 Aug; 61(8):1337-48. PubMed ID: 17627710
[TBL] [Abstract][Full Text] [Related]
20. Duloxetine in the long-term treatment of major depressive disorder.
Raskin J; Goldstein DJ; Mallinckrodt CH; Ferguson MB
J Clin Psychiatry; 2003 Oct; 64(10):1237-44. PubMed ID: 14658974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
